The Effectiveness of Breathing Therapy in Patients With Schizophrenia
NCT ID: NCT07150507
Last Updated: 2025-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2022-04-29
2023-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MBRS-Based Psychoeducation in Patients With Schizophrenia
NCT07130227
The Personal Recovery Based Psychoeducation For Schizophrenia
NCT06284096
The Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in Schizophrenia
NCT06820580
The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients
NCT07173192
The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
NCT07144592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Session 1: Preparatory Session
\*Meeting the patients \*Introducing the content of psychoeducation \*Emphasizing the importance of regular and timely attendance at training \*Determining training dates \*Sharing individuals' experiences and expectations
Session 1: Preparation Session
\*Meeting Patients \*Introducing the Content of Psychoeducation \*Emphasizing the Importance of Regular and Timely Attendance at Training \*Determining Training Dates \*Sharing Individuals' Experiences and Expectations
Session 2: Recognizing the Illness
\*What is schizophrenia? \*What are its symptoms? \*What does treatment involve?
Session 2: Recognizing the Illness
\*What is Schizophrenia? \*What are its Symptoms? \*What Does Treatment Include?
Session 3: Evaluating Treatment
\*Considerations regarding medication use \*Side effects of medication use \*Exacerbations in schizophrenia \*Premonitory symptoms.
Session 3: Treatment Evaluation
\*Things to Consider When Using Medication \*Side Effects of Medication \*Exacerbation of Schizophrenia \*Precursor Symptoms.
Session 4: *What is anger?
\*What are the symptoms of anger? \*What are the methods for coping with anger?
Session 4: What is anger?
\*What are the symptoms of anger? \*What are the methods for coping with anger?
Session 5: Communication *What is communication?
\*The importance of communication. \*Fundamentals of communication, self-language practice \*Ways to prevent communication difficulties.
Session 5: Communication
\*What is communication? \*The importance of communication. \*Fundamentals of communication, working on "I" language. \*Ways to prevent communication difficulties.
Session 6: What is relaxation?
What is progressive relaxation. Relaxation CD introduction
Session 6: What is relaxation?
What is progressive relaxation? Introducing a relaxation CD
Session 7: Relaxation
Performing the relaxation CD with patients
Session 7: Relaxation
Practicing the relaxation CD with patients
Session 8: Evaluation
\*Reinforcement of what has been learned. \*Evaluation of the program. \*Receiving feedback
Session 8: Evaluation
\*Reinforcing what has been learned. \*Evaluating the program. \*Obtaining feedback
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Session 1: Preparation Session
\*Meeting Patients \*Introducing the Content of Psychoeducation \*Emphasizing the Importance of Regular and Timely Attendance at Training \*Determining Training Dates \*Sharing Individuals' Experiences and Expectations
Session 2: Recognizing the Illness
\*What is Schizophrenia? \*What are its Symptoms? \*What Does Treatment Include?
Session 3: Treatment Evaluation
\*Things to Consider When Using Medication \*Side Effects of Medication \*Exacerbation of Schizophrenia \*Precursor Symptoms.
Session 4: What is anger?
\*What are the symptoms of anger? \*What are the methods for coping with anger?
Session 5: Communication
\*What is communication? \*The importance of communication. \*Fundamentals of communication, working on "I" language. \*Ways to prevent communication difficulties.
Session 6: What is relaxation?
What is progressive relaxation? Introducing a relaxation CD
Session 7: Relaxation
Practicing the relaxation CD with patients
Session 8: Evaluation
\*Reinforcing what has been learned. \*Evaluating the program. \*Obtaining feedback
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being diagnosed with schizophrenia
* Being between the ages of 18 and 60
* Being willing to participate in the study
* Being open to communication and cooperation
* Being in remission
Exclusion Criteria
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ataturk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mine CENGİZ
Lecturer Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mine Cengiz lecturer doctor
Role: PRINCIPAL_INVESTIGATOR
Ataturk University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ataturk University Faculty of Nursing
Erzurum, Yakutiye, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCENGİZ6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.